By Abigail W. Adams
Portland, Me., May 20 – Tricida Inc. priced $175 million of seven-year convertible notes after the market close on Tuesday at the cheap end of talk at par with a coupon of 3.5% and an initial conversion premium of 25%, according to a company news release.
Price talk was for a coupon of 3% to 3.5% and an initial conversion premium of 25% to 30%, according to a market source.
Goldman Sachs & Co. LLC was the bookrunner for the Rule 144A offering, which carries a greenshoe of $25 million.
The notes are contingently convertible until Feb. 15, 2027. They are non-callable until May 20, 2024 and then subject to a 130% hurdle.
They are putable upon a fundamental change.
The notes will be settled in cash, shares or a combination of both at the company’s option.
Net proceeds are expected to be $168.8 million, or $193 million if the greenshoe is exercised in full.
Proceeds will be used for working capital and general corporate purposes.
Tricida is a San Francisco-based pharmaceutical company.
Issuer: | Tricida Inc.
|
Securities: | Convertible senior notes
|
Amount: | $175 million
|
Greenshoe: | $25 million
|
Maturity: | May 15, 2027
|
Bookrunner: | Goldman Sachs & Co. LLC
|
Coupon: | 3.5%
|
Price: | Par
|
Yield: | 3.5%
|
Conversion premium: | 25%
|
Conversion price: | $33.23
|
Conversion rate: | 30.0978
|
Call options: | Non-callable until May 20, 2024 and then subject to a 130% hurdle
|
Put options: | Upon a fundamental change
|
Pricing date: | May 19
|
Settlement date: | May 22
|
Distribution: | Rule 144A
|
Talk: | Coupon of 3% to 3.5% and initial conversion premium of 25% to 30%
|
Stock symbol: | Nasdaq: TCDA
|
Stock price: | $26.58 at market close May 19
|
Market capitalization: | $1.33 billion
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.